Germline PTEN mutations have been linked to a variety of syndromes, grouped under the term PTEN Hamartoma Tumor Syndrome, characterized by benign growths and increased risk of developing certain types of cancers (Hollander et al., 2011). This evidence concerns the gene PTEN and cancer.